CapsoVision Inc. logo

CapsoVision Inc.

CV | NASDAQ
Chart Builder DCF Calculator
$6.83
-$0.11 (-1.59%)
At close: Oct 30, 2026, 4:00 PM ET
$6.83
$0.00 (0.00%)
Pre-market: Nov 2, 2026, 4:00 AM ET

Company Profile

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

Key Executives

Name Position
Kang Huai Wang Co-Founder, President, Chief Executive Officer & Director
Anna Krylova Corporate Controller
David Garcia Compliance Officer, SVP of Finance, Principal Financial & Accounting Officer
Douglas Atkinson Senior Vice President of Global Sales
Helen Chau Manager of Human Resources

Latest SEC Filings

Date Type Title
Sep 28, 2026 8-K Current Report
Sep 23, 2026 4 Filing
Sep 23, 2026 4/A [Amend] Filing
Sep 23, 2026 4/A [Amend] Filing
Sep 18, 2026 4 Filing
Sep 18, 2026 8-K Current Report
Sep 18, 2026 424B5 Filing
Aug 21, 2026 EFFECT Filing
Aug 21, 2026 424B5 Filing
Aug 18, 2026 8-K Current Report
View All SEC Filings ➞
CapsoVision Inc.
CapsoVision Inc. logo
Country United States
IPO Date Jul 2, 2025
Industry Medical - Devices
Sector Healthcare
Employees 99
CEO Kang-Huai Wang

Contact Details

18805 Cox Avenue Saratoga, California 95070 United States

Stock Details

Ticker Symbol CV
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001378325
CUSIP Number 140935107
ISIN Number US1409351079
SIC Code 3845

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.